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Fetomaternal bleeding has also been documented following both vaginal and cesarean deliveries, with some studies suggesting an increased risk with cesarean delivery, while others have not found this association. [7] [8] [9] One possible difference in these studies may lie in whether or not the placenta is transected during the cesarean delivery process. Through an extensive literature search using PubMed, Scopus, Medline, and Google Scholar, we found no prior study that has evaluated this question. If fetomaternal bleeding is greater in transplacental transection cesarean deliveries, then Rh-negative mothers who deliver Rh-positive newborns may need supplemental Rh-hyperimmune globulin. In addition, data are also limited regarding neonatal hematocrit postcesarean delivery in procedures where the placenta is transected. We sought to evaluate the rate of fetomaternal bleeding following routine cesarean delivery compared with cesarean delivery where transplacental transection was needed to accomplish delivery. The secondary study objective was to evaluate neonatal hematocrits postdelivery for each group.
Materials and Methods
Our study was a prospective cohort evaluation of cesarean delivery controls (the placenta was not transected to accomplish delivery) versus cases (transplacental transection occurred in the delivery process Conclusion A cesarean requiring transplacental transection to accomplish delivery does not significantly increase the rate of fetomaternal bleeding but is associated with a higher likelihood of newborn hematocrit <40% at delivery.
collected within 24 hours of delivery. For laboratory performance, our institution uses Laboratory Corporation of America (LabCorp) and for quantifying fetomaternal hemorrhage, LabCorp uses the KB test. Per LabCorp standardization, a test is considered positive with a cutoff level of 0.05%, suggesting a fetal bleed of 2.5 mL. A neonatal hematocrit was also obtained on the first day of life. Though various normal ranges for neonatal hematocrits have been described, values more than 40% do not usually require any specific follow-up. A value <40% was chosen for our lower level cutoff because at this level further analysis will occur to make sure the level does not decrease to a point where transfusion is needed. Data collection included demographics, gestational age at delivery, indication for cesarean delivery, type of uterine incision, those in labor prior to cesarean, manual removal of the placenta, and whether the placenta was transected to effect delivery of the fetus. Patients with any type of hemoglobinopathy were excluded.
A power analysis was performed based on data from the published studies to date that evaluated the rate of a positive KB test following cesarean delivery. As transplacental transection during cesarean delivery is not a frequent occurrence, a 2:1 ratio of routine cesarean versus transplacental transection cesarean was incorporated. For a power of 80 using an α of 0.05 and an expected rate of a positive KB test to be three times higher in the transplacental transection cases, a minimum of 90 patients was required (60 routine cesarean controls and 30 transplacental transection cases). The study progressed until the 30 transplacental transection cases were obtained. Cases number 30 and 31 were obtained on the same day in April 2018. The controls were obtained by November 2017, and no further controls were collected. A large fetomaternal bleed was considered at 15 mL or greater. As the estimation of the amount of fetal bleeding is not completely exact, to err on the side of safety, many blood banks use this cutoff value to determine if more than one vial of Rh-hyperimmunoglobulin should be administered. Statistics involved the Student's t-test, chi-square test, Mann-Whitney's U-test, Fisher's exact test, and multivariate analysis where appropriate, and a p-value <0.05 was considered significant with all tests considered against a two-sided alternative hypothesis. This study was reviewed and approved by the Institutional Review Board of the University of Tennessee Medical Center, Knoxville, TN.
Results
A total of 94 patients were evaluated with 63 routine cesarean controls compared with 31 transplacental transection cases. The demographics and characteristics of the study population are seen in ►Table 1, and no differences were found between the cases and controls except for manual removal of the placenta. As depicted, the study population was primarily Caucasian (89%), multiparous (73%), and underwent repeat cesarean delivery (69%).
Overall, there were 15 (16%) positive KB tests (►Table 2) with 9 (14%, 95% confidence interval [CI]: 7-25%) in the routine cesarean controls compared with 6 (19%, 95% CI: 7-31%) in the 31 transplacental cesarean cases (p ¼ 0.74). There were three large bleeds as defined, two in the controls and one in the cases (p ¼ 0.99). There was no difference in finding a positive KB test in the multiparous group (11 of 69, 16%) versus nulliparous group (4 of 25, 16%), p ¼ 0.99.
Though there were more instances of manual removal of the placenta in the cases (74%) versus controls (16%), this did not affect the rate of a positive KB test. Of the 23 cases, 5 (21.7%) had a positive KB test compared with 2 of 10 controls (20%), p ¼ 0.99. In analyzing all manual removals of the placenta compared with spontaneous placental delivery, again there was no difference in 7 of 33 (21.2%) versus 8 of 61 (13.1%), p ¼ 0.47. A multivariate analysis was performed using the variables in ►Table 1, and none was found to be significant for producing a higher rate of a positive KB test.
Mean neonatal hematocrits were not different (p ¼ 0.17). Median neonatal hematocrits with interquartile ranges were also not different with a z-score of 1.08 (p ¼0.28). However, for neonatal hematocrits <40%, there were two in the controls (3% CI: 0.4-11%) compared with seven in the transplacental transection group (23%, 95% CI: 10-41%), which was significant, p ¼ 0.005. However, none of these nine newborns required a blood transfusion postdelivery.
Discussion
This study did not find that a cesarean delivery that requires transplacental transection to accomplish delivery results in a greater risk for fetomaternal bleeding. However, a transplacental transection cesarean delivery did result in an increased risk for a newborn hematocrit to be <40% at delivery. Based on our literature review, this is the first study to analyze whether a transplacental transection cesarean delivery increases the risk for a fetomaternal hemorrhage. Feldman et al 10 reported a positive KB test rate of 18.6% in 199 cesarean deliveries, which is similar to our rate of 16%. However, their study used a lower KB cutoff value of 1 mL compared with our cutoff value of 2.5 mL and most of their study population involved cesarean delivery following labor. These authors also reported a 5% rate of a fetomaternal bleed of 25 mL or greater which was similar to our rate of 3% (3 of 94 study participants). Perslev et al 11 reported a fetomaternal hemorrhage rate of 18.4% in 207 elective cesarean deliveries using flow cytometry, but only 1.4% had a bleed of 5 mL or greater, which was lower than our rate of 14% (13 of 94 study participants). Lubusky et al 7 also used flow cytometry to assess fetomaternal hemorrhage and though they found a higher fetomaternal hemorrhage rate in cesarean delivery compared with vaginal delivery, they only reported a 2.3% rate of a bleed 5 mL or greater with cesarean delivery. Adeniji et al 8 used the KB test to evaluate the rate of a fetomaternal bleed in 163 deliveries (102 vaginal deliveries and 61 cesarean deliveries). The rate of a positive KB test overall was 10.4%, and the positive KB test rate between vaginal (9.8%) and cesarean delivery (11.5%) was not different. They reported a rate for a bleed of 15 mL or greater in the cesarean delivery group of 7% (4 of 61), which was higher but not statistically different from our rate of 3% (3 of 94), p ¼ 0.43. None of these studies examined the relationship of transplacental transection at the time of cesarean delivery.
Additionally, in our review, we found no study has reported on the newborn hematocrit following cesarean delivery with transplacental transection. Our study did show a significantly higher rate of a neonatal hematocrit <40% in these deliveries. A case of fetal exsanguination with demise was recently reported involving transection of the placenta at the time of cesarean delivery combined with difficulty in fetal head delivery further emphasizing a concern in this clinical setting.
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Our study did have a higher positive KB test rate in cesarean deliveries that involved manual removal of the placenta, though the comparison did not reach significance. This lack of significance, however, could represent a type 2 error, and therefore, this is an area that needs further study. Leavitt et al 13 demonstrated that draining the fetal blood from the umbilical cord prior to placental delivery did reduce the rate of a positive KB test (using a lower cutoff value of 0.5 mL of fetal blood) compared with nondrainage, and this could extrapolate somewhat into the potential effect of manual placental removal. None of our deliveries involved draining of the umbilical cord or delayed cord clamping. Likewise, we only had four cesarean deliveries that involved a classical uterine incision, and therefore, this study cannot answer the effect of this type of uterine entry on the rate of fetomaternal hemorrhage.
The strengths of our study are the prospective study design that controlled for the cesarean indication, type of uterine incision, and manual removal of the placenta, as well as attaining the numbers needed from the power analysis. A study limitation is the potential for a type 2 error. However, if the respective rates of a positive KB test rate between routine cesarean delivery and transplacental transection cesarean delivery were to remain unchanged, more than 10 times the number of cases and controls would be needed to reach significance. Additionally, as previously discussed, this analysis cannot answer whether manual placental removal or classical uterine incision is risk factors.
Finally, our study used the KB test to evaluate for volume of fetomaternal hemorrhage based on LabCorp protocol. This test is primarily performed because it is inexpensive, requires no special equipment, and is easy to perform in situations where rapid results are needed, which is often the case when [14] [15] [16] [17] However, the primary concern with fetomaternal hemorrhage in patients who are Rh-negative would be bleeds that exceed the threshold of one vial of Rhhyperimmune globulin. Both tests appear to be accurate in identifying large fetomaternal bleeds.
Conclusion
A cesarean requiring transplacental transection to accomplish delivery does not appear to significantly increase the rate of fetomaternal bleeding. However, a transplacental transection cesarean delivery may result in an increased risk for newborn hematocrits to be <40% following delivery. Therefore, we recommend that pediatrics be informed in clinical settings where the placenta was transected at the time of cesarean delivery, so these neonates can be evaluated.
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